AlphaYouSION: Fitzpatrick Jennifer discloses securities transactions
By AlphaYouPublished Form 4
Fitzpatrick Jennifer
Reporting filer
Fitzpatrick Jennifer reported Grant or award in Sionna Therapeutics, Inc.: 28133 units of Common Stock, dated 2026-09-17. The full Form 4 contains 4 transaction entries.
- Disclosed
- Sep 18, 2026
Reported details
4 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Fitzpatrick Jennifer | 2026-09-17 | A | Grant or award | 28133 | 0.0 | 28,133 | 1 day | Filed terms
|
| Common Stock | Fitzpatrick Jennifer | 2026-09-17 | A | Grant or award | 28132 | 0.0 | 56,265 | 1 day | Filed terms
|
| Non-Qualified Stock Option (right to buy) (derivative) | Fitzpatrick Jennifer | 2026-09-17 | A | Grant or award | 103140 | 0.0 | 103,140 | 1 day | Filed terms
|
| Non-Qualified Stock Option (right to buy) (derivative) | Fitzpatrick Jennifer | 2026-09-17 | D | Disposition to issuer | 103140 | 0.0 | 0 | 1 day | Filed terms
|
Common Stock
- Owner
- Fitzpatrick Jennifer
- Date
- 2026-09-17
- Code
- A
- Action
- Grant or award
- Quantity
- 28133
- Price
- 0.0
- Following holdings
- 28,133
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-17
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- id: F1
- transaction Shares: 28133
- transaction Price Per Share: 0.0
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 28133
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Fitzpatrick Jennifer
- Date
- 2026-09-17
- Code
- A
- Action
- Grant or award
- Quantity
- 28132
- Price
- 0.0
- Following holdings
- 56,265
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-17
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- id: F2
- transaction Shares: 28132
- transaction Price Per Share: 0.0
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 56265
- direct Or Indirect Ownership: D
Non-Qualified Stock Option (right to buy) (derivative)
- Owner
- Fitzpatrick Jennifer
- Date
- 2026-09-17
- Code
- A
- Action
- Grant or award
- Quantity
- 103140
- Price
- 0.0
- Following holdings
- 103,140
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Non-Qualified Stock Option (right to buy)
- conversion Or Exercise Price: 7.18
- id: F3
- transaction Date: 2026-09-17
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- id: F4
- transaction Shares: 103140
- transaction Price Per Share: 0.0
- id: F4
- transaction Acquired Disposed Code: A
- id: F5
- expiration Date: 2036-01-01
- underlying Security Title: Common Stock
- underlying Security Shares: 103140
- shares Owned Following Transaction: 103140
- direct Or Indirect Ownership: D
Non-Qualified Stock Option (right to buy) (derivative)
- Owner
- Fitzpatrick Jennifer
- Date
- 2026-09-17
- Code
- D
- Action
- Disposition to issuer
- Quantity
- 103140
- Price
- 0.0
- Following holdings
- 0
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Non-Qualified Stock Option (right to buy)
- conversion Or Exercise Price: 39.21
- transaction Date: 2026-09-17
- transaction Form Type: 4
- transaction Code: D
- equity Swap Involved: 0
- id: F4
- transaction Shares: 103140
- transaction Price Per Share: 0.0
- id: F4
- transaction Acquired Disposed Code: D
- id: F5
- expiration Date: 2036-01-01
- underlying Security Title: Common Stock
- underlying Security Shares: 103140
- shares Owned Following Transaction: 0
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Fitzpatrick Jennifer: CLO and Head of Program Mgmt..
- F1: Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest on June 17, 2027, subject to the Reporting Person's continued service with the Issuer as of the vesting date.
- F2: Represents a grant of RSUs. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest upon the achievement of a designated performance milestone, subject to the Reporting Person's continued service with the Issuer as of the vesting date.
- F3: The exercise price of the option is $7.18 per share, representing the fair market value per share of the Issuer's Common Stock on September 17, 2026 (the "Repricing Date"). Unless otherwise provided by the Issuer's board of directors or its compensation committee, if the option is exercised before the applicable retention period ends, the exercise price will revert to its original exercise price. The retention period begins on the Repricing Date and ends on the earliest of (i) the 18-month anniversary of the Repricing Date (March 17, 2028), (ii) a Sale Event (as defined in the Sionna Therapeutics, Inc. 2025 Stock Option and Incentive Plan (the "2025 Plan")) or (iii) certain qualifying terminations of service.
- F4: Effective on the Repricing Date, the Issuer's board of directors approved an option repricing. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.
- F5: This stock option award was issued pursuant to the 2025 Plan, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on the applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.
Original sources
Prepared automatically from public filing data. Report a correction.